Entry |
|
Name |
Mutation-activated MET to PI3K signaling pathway
|
Definition |
MET* -> GAB1 -> PI3K -> PIP3 -> AKT -| BAD |
Expanded |
4233v1 -> 2549 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -| 572 |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00048 | Hepatocellular carcinoma |
|
Gene |
4233 | MET; MET proto-oncogene, receptor tyrosine kinase |
2549 | GAB1; GRB2 associated binding protein 1 |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
572 | BAD; BCL2 associated agonist of cell death |
|
Variant |
4233v1 (MET*) MET kinase domain mutation
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. |
Title |
Met, metastasis, motility and more. |
Journal |
|
Reference |
|
Authors |
Bardelli A, Pugliese L, Comoglio PM |
Title |
"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection. |
Journal |
|
Reference |
|
Authors |
Breuhahn K, Longerich T, Schirmacher P |
Title |
Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Park WS, Dong SM, Kim SY, Na EY, Shin MS, Pi JH, Kim BJ, Bae JH, Hong YK, Lee KS, Lee SH, Yoo NJ, Jang JJ, Pack S, Zhuang Z, Schmidt L, Zbar B, Lee JY |
Title |
Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. |
Journal |
Cancer Res 59:307-10 (1999) |